This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 49/6/1291    most recent HYPERTENSIONAHA.106.085498v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, Y. Articles by Staessen, J. A. Search for Related Content PubMed PubMed Citation Articles by Li, Y. Articles by Staessen, J. A. Related Collections Clinical genetics Risk Factors Epidemiology

(Hypertension. 2007;49:1291.)
© 2007 American Heart Association, Inc.

Original Articles

Angiotensin-Converting Enzyme I/D and -Adducin Gly460Trp Polymorphisms

From Angiotensin-Converting Enzyme Activity to Cardiovascular Outcome

Yan Li; Laura Zagato; Tatiana Kuznetsova; Grazia Tripodi; Gianpaolo Zerbini; Tom Richart; Lutgarde Thijs; Paolo Manunta; Ji-Guang Wang; Giuseppe Bianchi; Jan A. Staessen

From the Studies Coordinating Centre (Y.L., T.K., T.R., L.T., J.A.S.), Division of Hypertension and Cardiovascular Research, Department of Cardiovascular Diseases, University of Leuven, Leuven, Belgium; Divisione di Nefrologia Dialisi e Ipertensione (L.Z., G.Z., P.M., G.B.), Ospedale San Raffaele, Dipartimento di Scienze e Technologie Biomediche, Universitá Vita Salute, Milan, Italy; Prassis Sigma-Tau Research Institute (G.T.), Settimo Milanese, Milan, Italy; and the Centre for Epidemiological Studies and Clinical Trials (Y.L., J-G.W.), Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Jiaotong University Medical School, Shanghai, People’s Republic of China.

Correspondence to Jan A. Staessen, Studies Coordinating Centre, Laboratory of Hypertension, Campus Gasthuisberg, Herestraat 49, Box 702, B-3000 Leuven, Belgium. E-mail jan.staessen{at}med.kuleuven.be

The angiotensin-converting enzyme (ACE) I/D and the -adducin (ADD1) Gly460Trp polymorphisms are associated with cardiovascular risk factors. In a prospective population study and in cell models, we investigated the combined effects of these 2 polymorphisms. We randomly recruited 1287 white subjects (women: 50.0%; mean age: 55.9 years). We obtained outcomes from registries and repeat examinations (median 3). Over 9.0 years (median), 178 fatal or nonfatal cardiovascular events occurred. In ADD1 Trp allele carriers, the multivariate-adjusted hazard ratios associated with ACE DD versus I were 1.72 (P=0.007) for total mortality, 2.35 (P=0.02) for cardiovascular mortality, 2.02 (P=0.005) for all cardiovascular events, and 2.59 (P=0.03) for heart failure. In contrast, these hazard ratios did not reach significance in ADD1 GlyGly homozygotes (0.08P0.90). The positive predictive value and attributable risk associated with ACE DD homozygosity combined with mutated ADD1 were 36.2% and 10.3%, respectively. To clarify our epidemiological observations, we investigated the effects of mutated human ADD1 on the membrane-bound ACE activity in fibroblasts from 51 volunteers and in transfected human embryonic kidney cells (31 experiments). In fibroblasts (5.10 versus 3.63 nanomoles of generated hippuric acid per milligram of protein per minute; P=0.0021) and human embryonic kidney cells (1.086 versus 0.081 nmol/mg per minute; P=0.017), the membrane-bound ACE activity increased in the presence but not absence of the ADD1 Trp allele. In conclusion, the combination of ACE DD homozygosity and mutated ADD1 worsened cardiovascular prognosis to a similar extent as classic risk factors, possibly because of increased membrane-bound ACE activity in subjects carrying the ADD1 Trp allele.

Key Words: adducin • angiotensin-converting enzyme • clinical genetics • epidemiology • risk factors

This article has been cited by other articles:

				P. Manunta, G. Lavery, C. Lanzani, P. S. Braund, M. Simonini, C. Bodycote, L. Zagato, S. Delli Carpini, C. Tantardini, E. Brioni, et al. Physiological Interaction Between {alpha}-Adducin and WNK1-NEDD4L Pathways on Sodium-Related Blood Pressure Regulation Hypertension, August 1, 2008; 52(2): 366 - 372. [Abstract] [Full Text] [PDF]